Oakley Bowden Pharma Private Limited
About Oakley Bowden Pharma Private Limited
Data last updated:
Oakley Bowden Pharma Private Limited was a private limited company based in Chennai, Tamil Nadu, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the real estate leasing and property management segment of the real estate sector. It was incorporated on 07 May 1993.
The company was registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN1993PTC025025. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹45 Lakh and a paid-up capital of ₹16.29 Lakh. It was led by directors Kishor Lal Daga and Thiyagarajan.
Its last annual general meeting (AGM) was held on 30 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at Unit N O 9B 3rd Floorr A Building No 72 Marshalls Road, Chennai, Tamil Nadu, India – 600008.
As per the financials filed for FY 2020, the company reported a revenue of ₹12.19 Lakh, a growth of 34% compared to the previous year. For the same year it recorded a net profit of ₹5.14 Lakh (net margin 42.2%) and EBITDA of ₹9.67 Lakh (EBITDA margin 79.3%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 3% over five years.
As per MCA filings, the company had satisfied charges of ₹50 Lakh on record.
Company details
Contact details
Oakley Bowden Pharma Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressUnit N O 9B 3rd Floorr A Building No 72 Marshalls Road, Chennai, Tamil Nadu, India – 600008
- IndustryReal Estate, Real Estate Leasing, Contractual Work
To see the full contact details of Oakley Bowden Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Oakley Bowden Pharma is real estate. In detail, this covers real estate activities on fee or contract basis.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| L | Real Estate | L2 | Real estate activities on fee or contract basis |
To see the full business activity and turnover split of Oakley Bowden Pharma Private Limited, buy the company report.
Financials of Oakley Bowden Pharma Private Limited
FY 2020 filings availableOakley Bowden Pharma Private Limited reported revenue of ₹12.19 Lakh (up 34% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 34% growth in the latest year. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.67 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.14 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 79.3% | ||||
| Net Profit Margin | 42.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Oakley Bowden Pharma Private Limited, buy the company report.
Board of directors of Oakley Bowden Pharma Private Limited
Oakley Bowden Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kishor Lal Daga Also directs: Daga Shelters LLP, Tablets (India) Ltd, Oaklands Properties Private Limited and 3 more | Director | 01 Nov 2009 | 17 Years 0 Months | As last reported |
| Thiyagarajan | Additional Director | 22 Jan 2021 | 5 Years 9 Months | As last reported |
Peer comparison
Oakley Bowden Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (real estate activities on fee or contract basis), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Heaven Promoters and Developers Private Limited | ₹12.25 Lakh (FY 2022) | -43.0% | Delhi, India | |||
| RGV Power Industries (OPC) Private Limited | ₹12.25 Lakh (FY 2025) | 19.0% | Noida, Uttar Pradesh, India | |||
| Welkin Promoters Private Limited | ₹12.23 Lakh (FY 2025) | -45.0% | Guwahati, Assam, India | |||
| Bhausaheb Jagtap and Company(Hotels) Pvt Ltd | ₹12.22 Lakh (FY 2025) | 9.0% | Nashik, Maharashtra, India | |||
| Juvo Online Services Private Limited | ₹12.21 Lakh (FY 2016) | 91.0% | Chennai, Tamil Nadu, India | |||
| Oakley Bowden Pharma Private Limitedthis company | ₹12.19 Lakh (FY 2020) | ₹5.14 Lakh | 42.2% | 34.0% | Chennai, Tamil Nadu, India | |
| Rahini Properties Private Limited | ₹12.18 Lakh (FY 2024) | -92.0% | Kolkata, West Bengal, India | |||
| Paharpur Realty Private Limited | ₹12.17 Lakh (FY 2025) | -81.0% | Kolkata, West Bengal, India | |||
| Dwellandkey Estates India Private Limited | ₹12.17 Lakh (FY 2021) | Bangalore, Karnataka, India | ||||
| Kotac Pharmaceuticals Private Limited | ₹12.17 Lakh (FY 2024) | -58.0% | Budaun, Uttar Pradesh, India | |||
| Gpsedificios (OPC) Private Limited | ₹12.16 Lakh (FY 2025) | -36.0% | Ludhiana, Punjab, India |
To see the full peer comparison of Oakley Bowden Pharma Private Limited, buy the company report.
Auditor
Oakley Bowden Pharma Private Limited is audited by M C RANGANATHAN AND COMPANY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M C RANGANATHAN AND COMPANY | FY 2017 | 003061S |
Shareholding
The shareholding of Oakley Bowden Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Oakley Bowden Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Jan 2004 | 90281593 | State Bank of India | ₹50 Lakh | Satisfied |
To see the full charge records of Oakley Bowden Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Oakley Bowden Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Oakley Bowden Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Oakley Bowden Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Oakley Bowden Pharma Private Limited, buy the company report.
Recent activity
Oakley Bowden Pharma Private Limited has 4 board changes on record since 2009: 2 appointments and 2 cessations. The latest: Suresh Kumar Sewag ceased to be Director on 22 Jan 2021.
Frequently asked questions
Oakley Bowden Pharma has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Oakley Bowden Pharma was a private limited company based in Chennai, Tamil Nadu, India. The company worked in real estate leasing, within the real estate industry. It was incorporated on 07 May 1993 and is registered under CIN U24231TN1993PTC025025. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Oakley Bowden Pharma was incorporated on 07 May 1993. It is registered with the Registrar of Companies, Chennai.
Oakley Bowden Pharma had 2 directors:
- Kishor Lal Daga - Director
- Thiyagarajan - Additional Director
The CIN (Corporate Identification Number) of Oakley Bowden Pharma is U24231TN1993PTC025025. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Oakley Bowden Pharma is at Unit N O 9B 3rd Floorr A Building No 72 Marshalls Road, Chennai, Tamil Nadu, India – 600008.
The latest financial statements of Oakley Bowden Pharma on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 30 December 2020. Year-wise statements from 2015 are in the company report.
No. Oakley Bowden Pharma has 1 GST registration on record and it is cancelled or inactive.
Oakley Bowden Pharma operated in the real estate industry, in the real estate leasing segment.
The peers of Oakley Bowden Pharma by revenue are Heaven Promoters and Developers Private Limited, RGV Power Industries (OPC) Private Limited, Welkin Promoters Private Limited, Bhausaheb Jagtap and Company(Hotels) Pvt Ltd, Juvo Online Services Private Limited and 5 more, all in the same principal business activity (real estate activities on fee or contract basis).
Suresh Kumar Sewag ceased to be Director on 22 Jan 2021. Thiyagarajan was appointed as Additional Director on 22 Jan 2021. Kishor Lal Daga was appointed as Director on 01 Nov 2009. Oakley Bowden Pharma has 4 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
